Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GSPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FLOT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf174 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927446 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPHOSPH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R5C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB11FIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OXA1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLPTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAND2P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SDHC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAI3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTPAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBSCR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on